Statin-Associated Rhabdomyolysis: Is There a Dose-Response Relationship?
Open Access
- 30 April 2011
- journal article
- case report
- Published by Elsevier BV in Canadian Journal of Cardiology
- Vol. 27 (2), 146-151
- https://doi.org/10.1016/j.cjca.2010.12.024
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Muscle toxicity with statinsPharmacoepidemiology and Drug Safety, 2009
- Narrative Review: Statin-Related MyopathyAnnals of Internal Medicine, 2009
- The broad spectrum of statin myopathy: from myalgia to rhabdomyolysisCurrent Opinion in Lipidology, 2007
- Clinical Perspectives of Statin-Induced RhabdomyolysisThe American Journal of Medicine, 2006
- High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial InfarctionThe IDEAL Study: A Randomized Controlled TrialJAMA, 2005
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary DiseaseThe New England Journal of Medicine, 2005
- Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering DrugsJAMA, 2004
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesThe New England Journal of Medicine, 2004
- Expanding Statin Use to Help More At-Risk Patients Is Causing Financial HeartburnJAMA, 2003